Concepedia

Katalin Keltai

KK

22

Publications

8.4K

Citations

18

H-Index

2004

Active since

Affiliations

Semmelweis University(Current)

Population Health Research Institute

McMaster University

Hamilton Health Sciences

University of Edinburgh

Katalin Keltai is an author at Semmelweis University specializing in medicine, cardiovascular disease, and atherosclerosis.

ORCID

Top concepts

Publications per year

2004–2023

22

Publications

22

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

, , +13

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Salim Yusuf, Jackie Bosch, Gilles R. Dagenais et al. · New England Journal of Medicine · 2016 · 827 citations · Full text

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

, , +12

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Eva Lonn, Jackie Bosch, Patricio López‐Jaramillo et al. · New England Journal of Medicine · 2016 · 610 citations · Full text

Rows per page

1–5 of 22